Filter
3172
Filtered Results: 3172
Text search:
laboratory-confirmed
Featured
Recommendations
389
New Publications
859
Language
Document type
No document type
1709
Guidelines
648
Studies & Reports
364
Strategic & Response Plan
142
Manuals
133
Fact sheets
65
Situation Updates
60
Training Material
33
Infographics
7
Resource Platforms
6
Brochures
2
Online Courses
2
App
1
Countries / Regions
India
140
Sierra Leone
111
Liberia
96
Western and Central Europe
82
Global
80
Kenya
74
South Africa
68
Latin America and the Carribbean
67
Nigeria
66
Rwanda
61
Africa
59
Ethiopia
59
Uganda
54
Tanzania
49
Colombia
46
Congo, Democratic Republic of
44
Malawi
43
Zambia
42
Guinea
41
Nepal
40
Brazil
35
Bangladesh
34
Paraguay
33
Ghana
32
West and Central Africa
32
Eastern Europe
32
Syria
29
Bolivia
29
East and Southern Africa
28
Philippines
27
Ukraine
22
Venezuela
22
Myanmar / Burma
22
Zimbabwe
21
Mozambique
21
Namibia
21
Middle East and North Africa
20
South–East Asia Region
20
Ecuador
20
Argentina
19
Cambodia
18
Peru
17
Russia
17
Lesotho
15
El Salvador
14
Eastern Europe and Central Asia
14
South Sudan
14
Senegal
12
Germany
12
Mali
12
Angola
12
Burkina Faso
11
Haiti
11
Chile
10
Botswana
10
Pakistan
10
Asia
9
Western Pacific Region
9
Spain
9
Yemen
9
Madagascar
9
USA
8
Indonesia
7
Somalia
7
Albania
6
Afghanistan
6
Guinea-Bissau
6
Côte d’Ivoire / Ivory Coast
5
Moldova
5
Iraq
5
Tajikistan
4
Thailand
4
Cameroon
4
Niger
4
Burundi
4
Saudi Arabia
4
Lebanon
4
Sudan
4
Georgia
4
Honduras
4
Chad
4
Eswatini/ Swaziland
4
Iran
3
Laos
3
Dominican Republic
3
United Kingdom
3
Portugal
3
Southern Africa
3
Vietnam
3
Papua New Guinea
3
Palestine
3
Central African Republic
3
North Macedonia
2
Timor Leste/ East Timor
2
Mexico
2
Turkey
2
Benin
2
Gambia
2
Togo
2
China
2
Uzbekistan
2
Qatar
2
Italy
2
Armenia
2
Jordan
2
North America
2
France
2
Sri Lanka
2
Serbia
1
Australia
1
Kazakhstan
1
Estonia
1
Congo-Brazzaville
1
Morocco
1
Bulgaria
1
Lithuania
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Japan
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Nicaragua
1
Djibouti
1
Egypt
1
Greece
1
Poland
1
Libya
1
Bhutan
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1305
Clinical Guidelines
369
Public Health
119
Key Resources
84
Women & Child Health
78
Pharmacy & Technologies
66
Capacity Building
40
Toolboxes
COVID-19
541
TB
373
Rapid Response
248
Ebola
217
HIV
210
NTDs
130
AMR
79
Zika
77
Mental Health
56
Cholera
52
Pharmacy
49
Conflict
39
Polio
31
Caregiver
30
Refugee
29
Planetary Health
26
Specific Hazards
21
NCDs
19
Global Health Education
11
Natural Hazards
10
Health Financing Toolbox
10
Disability
5
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been made by harnessing the mostly informal relationships that exist between partners including Member Stat...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease. Endemic in 21 Latin American countries, the disease can be transmitted by vector insects called triatomines — also known as “kissing bugs” —, foods or beverages contaminated with th...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
The sub-Saharan African region, carries 90% of the over 250 million cases of schistosomiasis occurring worldwide. In this region, after Nigeria, Tanzania is second country having the highest cases of schistosomiasis and approximately 51.5%0 of the Tanzanian population is either exposed or live in ar...
Schistosoma haematobium is a parasitic digenetic trematode responsible for schistosomiasis (also known as bilharzia). The disease is caused by penetration of the skin by the parasite, spread by intermediate host molluscs in stagnant waters, and can be treated by administration of praziquantel. Schis...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
